Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease

M.I. Kester, C.E. Teunissen, D.L. Crimmins, E.M. Herries, J.H. Ladenson, P. Scheltens, W.M. van der Flier, J.C. Morris, D.M. Holtzman, A.M. Fagan

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1275-1280
JournalJAMA Neurology
Volume72
Issue number11
DOIs
Publication statusPublished - 2015

Cite this

Kester, M.I. ; Teunissen, C.E. ; Crimmins, D.L. ; Herries, E.M. ; Ladenson, J.H. ; Scheltens, P. ; van der Flier, W.M. ; Morris, J.C. ; Holtzman, D.M. ; Fagan, A.M. / Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease. In: JAMA Neurology. 2015 ; Vol. 72, No. 11. pp. 1275-1280.
@article{bfbf892aad1a4544ace63c68100f4571,
title = "Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease",
author = "M.I. Kester and C.E. Teunissen and D.L. Crimmins and E.M. Herries and J.H. Ladenson and P. Scheltens and {van der Flier}, W.M. and J.C. Morris and D.M. Holtzman and A.M. Fagan",
year = "2015",
doi = "10.1001/jamaneurol.2015.1867",
language = "Undefined/Unknown",
volume = "72",
pages = "1275--1280",
journal = "JAMA Neurology",
issn = "2168-6149",
publisher = "American Medical Association",
number = "11",

}

Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease. / Kester, M.I.; Teunissen, C.E.; Crimmins, D.L.; Herries, E.M.; Ladenson, J.H.; Scheltens, P.; van der Flier, W.M.; Morris, J.C.; Holtzman, D.M.; Fagan, A.M.

In: JAMA Neurology, Vol. 72, No. 11, 2015, p. 1275-1280.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease

AU - Kester, M.I.

AU - Teunissen, C.E.

AU - Crimmins, D.L.

AU - Herries, E.M.

AU - Ladenson, J.H.

AU - Scheltens, P.

AU - van der Flier, W.M.

AU - Morris, J.C.

AU - Holtzman, D.M.

AU - Fagan, A.M.

PY - 2015

Y1 - 2015

U2 - 10.1001/jamaneurol.2015.1867

DO - 10.1001/jamaneurol.2015.1867

M3 - Article

VL - 72

SP - 1275

EP - 1280

JO - JAMA Neurology

JF - JAMA Neurology

SN - 2168-6149

IS - 11

ER -